v3.25.4
Condensed Consolidated Statements of Cash Flow (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Operating activities:    
Net loss $ (4,071) $ (14,885)
Adjustments to reconcile net loss to cash used for operating activities:    
Depreciation and amortization 24,249 24,740
Stock-based compensation 1,166 902
Deferred income tax 1,808 2,851
Other, net 1,300 6,173
Changes in assets and liabilities:    
Decrease in accounts receivable 18,743 30,330
Increase in inventory (13,669) (8,602)
Increase in other current assets (7,043) (8,985)
Decrease in accounts payable (13,982) (16,548)
Decrease in accrued liabilities (19,022) (22,558)
Decrease in income taxes payable (5,203) (5,087)
Other, net (4,484) (841)
Cash used for operating activities (20,208) (12,510)
Investing activities:    
Capital expenditures (11,294) (11,624)
Proceeds from disposition of capital assets 55 169
Cash used for investing activities (11,239) (11,455)
Financing activities:    
Borrowings under credit facility 57,000 45,000
Repayments of credit facility borrowings (36,250) (56,250)
Repayments of other long-term debt (838) (2,026)
Common stock dividends paid (3,638) (3,812)
Issuance of common stock 0 214
Payroll tax paid to settle shares forfeited upon vesting of stock (354) (1,400)
Purchase of treasury stock 0 (3,698)
Cash provided by (used for) financing activities 15,920 (21,972)
Effect of exchange rate changes on cash, cash equivalents and restricted cash 2,052 (1,590)
Decrease in cash, cash equivalents and restricted cash (13,475) (47,527)
Cash, cash equivalents and restricted cash at beginning of period 78,118 102,995
Cash, cash equivalents and restricted cash at end of period $ 64,643 $ 55,468